Clarivate's stock has underperformed relative ... in real-world data and an uptick in pharmaceutical spending. These factors could provide a boost to the segment's growth prospects in the coming ...
2023 Journal Citation Reports® Science Edition (Clarivate Analytics, 2024) Partnering with our extensive network of expert ... We help your research reach more people and maximize its impact. As an ...
Clarivate also announced that it prepaid $75 ... These risks and uncertainties include, but are not limited to, those factors described in Item 1A. Risk Factors of our annual report on Form ...